Documentos de Almoguera B. | REDI

Regresar

Mostrando 4 resultados de: 4

Subtipo de publicación

Publisher

BMC Medical Genetics(1)

Pharmacogenetics and Genomics(1)

Pharmacogenomics(1)

Pharmacogenomics Journal(1)

Área temáticas

Enfermedades(2)

Farmacología y terapéutica(2)

Medicina y salud(2)

Fisiología humana(1)

Área de conocimiento

Farmacología(2)

Psicopatología(2)

Año de Publicación

Origen

Palabras Claves

pharmacogenetics(3)

Adverse events(1)

Antipsychotic(1)

Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population

Abstract: Risperidone non-compliance is often high due to undesirable side effects, whose development is in pa

Palabras claves:

Adverse events, Antipsychotic, pharmacogenetics, Risperidone

Abad-Santos F., Adrián LLerena, Almoguera B., Ayuso C., Baca-García E., Dal-Ré R., Dorado P., Fernandez-Piqueras J., Lopez-Castroman J., Riveiro-Alvarez R., Vaquero-Lorenzo C.

CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment

Abstract: The variability in the antipsychotic response is, to some extent, genetically determined. Several st

Palabras claves:

CYP2D6, EFFECTIVENESS, MDR1, pharmacogenetics, Risperidone, Schizophrenia

Abad-Santos F., Adrián LLerena, Almoguera B., Ayuso C., Baca-García E., Dal-Ré R., Dorado P., Fernandez-Piqueras J., Lopez-Castroman J., Riveiro-Alvarez R., Vaquero-Lorenzo C.

ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: A case control study

Abstract: Background: Three IL-10 gene promoter single nucleotide polymorphisms -1082G > A, -819C > T and -592

Palabras claves:

Abad-Santos F., Adrián LLerena, Almoguera B., Ayuso C., Baca-García E., Dal-Ré R., Dorado P., Fernandez-Navarro P., Fernandez-Piqueras J., Lopez-Castroman J., Lopez-Rodriguez R., Riveiro-Alvarez R.

Evaluating a newly developed pharmacogenetic array: Screening in a Spanish population

Abstract: Aims: How genes affect the response in a patient to a given medication is still poorly understood; t

Palabras claves:

accuracy, CYP2D6, PHARMAChip array ®, pharmacogenetics, sensitivity, SLC6A4, Specificity, successful genotyping rate

Abad-Santos F., Adrián LLerena, Almoguera B., Ayuso C., Dal-Ré R., Dorado P., Fernandez-Piqueras J., Gomez-Dominguez B., Lopez-Rodriguez R., Riveiro-Alvarez R., Vaquero-Lorenzo C.